<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39416989</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2328-8957</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Open forum infectious diseases</Title><ISOAbbreviation>Open Forum Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Symptoms Six Weeks After COVID-19 Are Reduced Among US Health Care Personnel Receiving Additional Vaccine Doses During the Omicron Period, December 2021-April 2022.</ArticleTitle><Pagination><StartPage>ofae545</StartPage><MedlinePgn>ofae545</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">ofae545</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/ofid/ofae545</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">The objective of this study was to test the hypothesis that subsequent doses of the coronavirus disease 2019 (COVID-19) vaccine are associated with lower incidence of COVID-19-like symptoms at 6 weeks after infection.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This study was a case-control analysis of health care personnel in an ongoing multicenter COVID-19 vaccine effectiveness study. We enrolled participants at the time of COVID-19-like symptoms between December 19, 2021, and April 27, 2022, which corresponded to the early Omicron-predominant period after original monovalent severe acute respiratory syndrome coronavirus 2 additional vaccination doses became available. Our outcome was self-reported symptoms completed 6 weeks after the onset of symptoms.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">We enrolled 2478 participants, of whom 1422 (57%) had COVID-19. The prevalence of symptoms at 6 weeks was 26% (n = 373) in those with COVID-19 and 18% (n = 195) in those without COVID-19. Fatigue (11%) and difficulty sleeping (7%) were most strongly associated with COVID-19. A total of 1643 (66%) participants received a subsequent vaccine dose (after the primary series). Participants with COVID-19 who had received a subsequent vaccination had lower odds of symptoms at 6 weeks (adjusted odds ratio [aOR], 0.55; 95% CI, 0.43-0.70), but this relationship was not observed in those without COVID-19 (aOR, 0.87; 95% CI, 0.59-1.29).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Health care personnel who received subsequent doses of original monovalent COVID-19 vaccine had a lower prevalence of symptoms at 6 weeks than those that did not.</AbstractText><CopyrightInformation>© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mohr</LastName><ForeName>Nicholas M</ForeName><Initials>NM</Initials><Identifier Source="ORCID">0000-0003-0497-5828</Identifier><AffiliationInfo><Affiliation>University of Iowa, City Iowa, Iowa, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Plumb</LastName><ForeName>Ian D</ForeName><Initials>ID</Initials><Identifier Source="ORCID">0000-0003-4747-381X</Identifier><AffiliationInfo><Affiliation>Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos León</LastName><ForeName>Eliezer</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>University of Iowa, City Iowa, Iowa, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinckney</LastName><ForeName>Malea</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Iowa State University, Ames, Iowa, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harland</LastName><ForeName>Karisa K</ForeName><Initials>KK</Initials><Identifier Source="ORCID">0000-0001-9482-8447</Identifier><AffiliationInfo><Affiliation>University of Iowa, City Iowa, Iowa, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krishnadasan</LastName><ForeName>Anusha</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Olive View-and Ronald Reagan University of California Los Angeles Medical Center, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoth</LastName><ForeName>Karin F</ForeName><Initials>KF</Initials><AffiliationInfo><Affiliation>University of Iowa, City Iowa, Iowa, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rwamwejo</LastName><ForeName>Fernand</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haran</LastName><ForeName>John P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Briggs-Hagen</LastName><ForeName>Melissa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kontowicz</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>University of Iowa, City Iowa, Iowa, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Talan</LastName><ForeName>David A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>University of Iowa, City Iowa, Iowa, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Olive View-and Ronald Reagan University of California Los Angeles Medical Center, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Project PREVENT Network </CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Open Forum Infect Dis</MedlineTA><NlmUniqueID>101637045</NlmUniqueID><ISSNLinking>2328-8957</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">COVID-19 vaccines</Keyword><Keyword MajorTopicYN="N">post-acute COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">vaccine efficacy</Keyword></KeywordList><CoiStatement>Potential conflicts of interest. The authors report no conflicts of interest.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Krispin</LastName><ForeName>Sydney</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schuette</LastName><ForeName>Allison</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tozloski</LastName><ForeName>Jillian</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>O'Brian</LastName><ForeName>Lili</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>McCormick</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hopcia</LastName><ForeName>Karen</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Orechia</LastName><ForeName>Theresa M</ForeName><Initials>TM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hill</LastName><ForeName>Alexander B</ForeName><Initials>AB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Donohoe</LastName><ForeName>Gabrielle</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Johnsky</LastName><ForeName>Lily R</ForeName><Initials>LR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fofi</LastName><ForeName>Jordyn M</ForeName><Initials>JM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Miyawaki</LastName><ForeName>Steven E</ForeName><Initials>SE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kaithamattam</LastName><ForeName>Jenson J</ForeName><Initials>JJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chung</LastName><ForeName>Michelle</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Umale</LastName><ForeName>Nikita A</ForeName><Initials>NA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hasdianda</LastName><ForeName>Mohammad Adrian</ForeName><Initials>MA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jambaulikar</LastName><ForeName>Guruprasad</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Teymour</LastName><ForeName>Tala</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Davila</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fernandez</LastName><ForeName>Suzette</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Krebs</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tiao</LastName><ForeName>Joshua</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wisniewski</LastName><ForeName>Stacey</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bernadas-Hunt</LastName><ForeName>Gaynell</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vandeerlin</LastName><ForeName>Alexander</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bett</LastName><ForeName>Domnic</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leggio</LastName><ForeName>Cathryn</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Henderson</LastName><ForeName>Alexandria</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Padilla</LastName><ForeName>Reynaldo</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Delgado</LastName><ForeName>Cynthia</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Manahan</LastName><ForeName>Madeleine</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hacopian</LastName><ForeName>Susana</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yu</LastName><ForeName>Vincent E</ForeName><Initials>VE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Potts</LastName><ForeName>Melanie</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kuo</LastName><ForeName>Jessica</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fowlds</LastName><ForeName>Alyssa</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Choxom</LastName><ForeName>Lidia</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dakos</LastName><ForeName>Amy</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tritt</LastName><ForeName>Denise</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Speight</LastName><ForeName>Zoe</ForeName><Initials>Z</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kemble</LastName><ForeName>Laurie</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Beckham</LastName><ForeName>Danielle</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hermanns</LastName><ForeName>Cecile</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Green</LastName><ForeName>Geneatra</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marrs</LastName><ForeName>Rachel</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schneider</LastName><ForeName>Katherine</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fairfield</LastName><ForeName>Catherine</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Landers</LastName><ForeName>Shannon</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Santos</LastName><ForeName>Eliezer</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kramer</LastName><ForeName>Nathan R</ForeName><Initials>NR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ullrich</LastName><ForeName>Fred</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mangolds</LastName><ForeName>Virginia</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nelson</LastName><ForeName>Morgan</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lopes</LastName><ForeName>Abigail</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Galbraith</LastName><ForeName>James</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Solis</LastName><ForeName>Lucia</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Peacock</LastName><ForeName>Rebekah</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jones</LastName><ForeName>Alan</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Navalkele</LastName><ForeName>Bhagyashri</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vann</LastName><ForeName>Savannah</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kile</LastName><ForeName>Alexander</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rodgers</LastName><ForeName>Joel</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Patkar</LastName><ForeName>Nivedita</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tidwell-Hand</LastName><ForeName>Delissa</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Covington</LastName><ForeName>Whitney</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kurz</LastName><ForeName>Michael C</ForeName><Initials>MC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Poerzgen</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fuentes</LastName><ForeName>Megan</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Anderson</LastName><ForeName>Layla A</ForeName><Initials>LA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Steinbock</LastName><ForeName>Kyle A</ForeName><Initials>KA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zelikoff</LastName><ForeName>Alison</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lynch</LastName><ForeName>John B</ForeName><Initials>JB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smith</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Abedi</LastName><ForeName>Glen R</ForeName><Initials>GR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nyanseor</LastName><ForeName>Sankan</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Watts</LastName><ForeName>Christopher K</ForeName><Initials>CK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gist</LastName><ForeName>Jade James</ForeName><Initials>JJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Saydah</LastName><ForeName>Sharon</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>McCullough</LastName><ForeName>Matthew</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Krebs</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smithline</LastName><ForeName>Howard A</ForeName><Initials>HA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hou</LastName><ForeName>Peter C</ForeName><Initials>PC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lee</LastName><ForeName>Lilly C</ForeName><Initials>LC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lim</LastName><ForeName>Stephen C</ForeName><Initials>SC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moran</LastName><ForeName>Gregory J</ForeName><Initials>GJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Steele</LastName><ForeName>Mark T</ForeName><Initials>MT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Beiser</LastName><ForeName>David G</ForeName><Initials>DG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Faine</LastName><ForeName>Brett</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nandi</LastName><ForeName>Utsav</ForeName><Initials>U</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schrading</LastName><ForeName>Walter A</ForeName><Initials>WA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chinnock</LastName><ForeName>Brian</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chipman</LastName><ForeName>Anne</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Crider</LastName><ForeName>Christine D</ForeName><Initials>CD</Initials></Investigator><Investigator ValidYN="Y"><LastName>LoVecchio</LastName><ForeName>Frank</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Horcher</LastName><ForeName>Alysia</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wallace</LastName><ForeName>Kelli</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Uribe</LastName><ForeName>Lisandra</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pathmarajah</LastName><ForeName>Kavitha</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Girardin</LastName><ForeName>Abigail L</ForeName><Initials>AL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hashimoto</LastName><ForeName>Dean M</ForeName><Initials>DM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bahamon</LastName><ForeName>Monica</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>St Romain</LastName><ForeName>Michelle</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kean</LastName><ForeName>Efrat</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mankoff</LastName><ForeName>Zachary</ForeName><Initials>Z</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stubbs</LastName><ForeName>Amy</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Roy</LastName><ForeName>Sara</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Volturo</LastName><ForeName>Gregory</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Higgins</LastName><ForeName>Amanda</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Galbraith</LastName><ForeName>James</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Crosby</LastName><ForeName>James C</ForeName><Initials>JC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mulrow</LastName><ForeName>Mary</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gonzalez</LastName><ForeName>Eva</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vakkalanka</LastName><ForeName>J Priyanka</ForeName><Initials>JP</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>17</Day><Hour>10</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>17</Day><Hour>10</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>17</Day><Hour>5</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39416989</ArticleId><ArticleId IdType="pmc">PMC11481461</ArticleId><ArticleId IdType="doi">10.1093/ofid/ofae545</ArticleId><ArticleId IdType="pii">ofae545</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hadj Hassine  I. COVID-19 vaccines and variants of concern: a review. Rev Med Virol  2022; 32:e2313.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8646685</ArticleId><ArticleId IdType="pubmed">34755408</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang  H, Paulson  KR, Pease  SA, et al.  Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21. Lancet  2022; 399:1513–36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8912932</ArticleId><ArticleId IdType="pubmed">35279232</ArticleId></ArticleIdList></Reference><Reference><Citation>
Centers for Disease Control and Prevention . COVID data tracker. 2023. Available at: https://covid.cdc.gov/covid-data-tracker/#datatracker-home. Accessed March 1, 2024.</Citation></Reference><Reference><Citation>Davis  HE, McCorkell  L, Vogel  JM, Topol  EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol  2023; 21:133–46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Adjaye-Gbewonyo  D, Vahratian  A, Perrine  CG, Bertolli  J.  Long COVID in Adults: United States, 2022. NCHS Data Brief, No 480. Centers for Disease Control and Prevention; 2023.</Citation><ArticleIdList><ArticleId IdType="pubmed">37756137</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian  A, Sehgal  K, Gupta  A, et al.  Post-acute COVID-19 syndrome. Nat Med  2021; 27:601–15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>van Kessel  SAM, Hartman  TCO, Lucassen  P, van Jaarsveld  CHM. Post-acute and long-COVID-19 symptoms in patients with mild diseases: a systematic review. Fam Pract  2022; 39:159–67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8414057</ArticleId><ArticleId IdType="pubmed">34268556</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabacof  L, Tosto-Mancuso  J, Wood  J, et al.  Post-acute COVID-19 syndrome negatively impacts physical function, cognitive function, health-related quality of life, and participation. Am J Phys Med Rehabil  2022; 101:48–52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8667685</ArticleId><ArticleId IdType="pubmed">34686631</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogungbe  O, Slone  S, Alharthi  A, et al.  “Living like an empty gas tank with a leak”: mixed methods study on post-acute sequelae of COVID-19. PLoS One  2022; 17:e0279684.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9803174</ArticleId><ArticleId IdType="pubmed">36584125</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet  M, Dercon  Q, Harrison  PJ. Six-month sequelae of post-vaccination SARS-CoV-2 infection: a retrospective cohort study of 10,024 breakthrough infections. Brain Behav Immun  2022; 103:154–62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9013695</ArticleId><ArticleId IdType="pubmed">35447302</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohr  NM, Plumb  ID, Harland  KK, et al.  Presence of symptoms 6 weeks after COVID-19 among vaccinated and unvaccinated US healthcare personnel: a prospective cohort study. BMJ Open  2023; 13:e063141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9895915</ArticleId><ArticleId IdType="pubmed">36731936</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe  A, Iwagami  M, Yasuhara  J, Takagi  H, Kuno  T. Protective effect of COVID-19 vaccination against long COVID syndrome: a systematic review and meta-analysis. Vaccine  2023; 41:1783–90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9905096</ArticleId><ArticleId IdType="pubmed">36774332</ArticleId></ArticleIdList></Reference><Reference><Citation>Byambasuren  O, Stehlik  P, Clark  J, Alcorn  K, Glasziou  P. Effect of COVID-19 vaccination on long COVID: systematic review. BMJ Med  2023; 2:e000385.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9978692</ArticleId><ArticleId IdType="pubmed">36936268</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaweethai  T, Jolley  SE, Karlson  EW, et al.  Development of a definition of postacute sequelae of SARS-CoV-2 infection. JAMA  2023; 329:1934–46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilishvili  T, Gierke  R, Fleming-Dutra  KE, et al.  Effectiveness of mRNA COVID-19 vaccine among U.S. health care personnel. N Engl J Med  2021; 385:e90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8482809</ArticleId><ArticleId IdType="pubmed">34551224</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm  E, Altman  DG, Egger  M, Pocock  SJ, Gøtzsche  PC, Vandenbroucke  JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet  2007; 370:1453–7.</Citation><ArticleIdList><ArticleId IdType="pubmed">18064739</ArticleId></ArticleIdList></Reference><Reference><Citation>45 C.F.R. part 46.102(l)(2), 21 C.F.R. part 56; 42 U.S.C. §241(d); 5 U.S.C. §552a; 44 U.S.C. §3501 et seq.</Citation></Reference><Reference><Citation>Fernandez-Montero  A, Argemi  J, Rodríguez  JA, Arino  AH, Moreno-Galarraga  L. Validation of a rapid antigen test as a screening tool for SARS-CoV-2 infection in asymptomatic populations. Sensitivity, specificity and predictive values. EClinicalMedicine  2021; 37:100954.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8189541</ArticleId><ArticleId IdType="pubmed">34127960</ArticleId></ArticleIdList></Reference><Reference><Citation>Pabbaraju  K, Wong  AA, Douesnard  M, et al.  Development and validation of RT-PCR assays for testing for SARS-CoV-2. J Assoc Med Microbiol Infect Dis Can 2021; 6:16–22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9612431</ArticleId><ArticleId IdType="pubmed">36340215</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer  B, Torriani  G, Yerly  S, et al.  Validation of a commercially available SARS-CoV-2 serological immunoassay. Clin Microbiol Infect  2020; 26:1386–94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7320699</ArticleId><ArticleId IdType="pubmed">32603801</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention. Long COVID or post-COVID conditions. 2023. Available at: https://archive.cdc.gov/#/details?url=https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html. Accessed March 8, 2024.</Citation></Reference><Reference><Citation>Carazo  S, Talbot  D, Boulianne  N, et al.  Single-dose messenger RNA vaccine effectiveness against severe acute respiratory syndrome coronavirus 2 in healthcare workers extending 16 weeks postvaccination: a test-negative design from Québec, Canada. Clin Infect Dis  2022; 75:e805–13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8522396</ArticleId><ArticleId IdType="pubmed">34460902</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde  MW, Self  WH, Adams  K, et al.  Influenza and Other Viruses in the Acutely Ill (IVY) Network. Association between mRNA vaccination and COVID-19 hospitalization and disease severity. JAMA  2021; 326:2043–54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8569602</ArticleId><ArticleId IdType="pubmed">34734975</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferdinands  JM, Rao  S, Dixon  BE, et al.  Waning 2-dose and 3-dose effectiveness of mRNA vaccines against COVID-19-associated emergency department and urgent care encounters and hospitalizations among adults during periods of Delta and Omicron variant predominance - VISION network, 10 states, August 2021-January 2022. MMWR Morb Mortal Wkly Rep  2022; 71:255–63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8853475</ArticleId><ArticleId IdType="pubmed">35176007</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani  D, Bosworth  ML, King  S, et al.  Risk of long COVID in people infected with severe acute respiratory syndrome coronavirus 2 after 2 doses of a coronavirus disease 2019 vaccine: community-based, matched cohort study. Open Forum Infect Dis  2022; 9:XXX–XX.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9494414</ArticleId><ArticleId IdType="pubmed">36168555</ArticleId></ArticleIdList></Reference><Reference><Citation>Tannous  J, Pan  AP, Potter  T, et al.  Real-world effectiveness of COVID-19 vaccines and anti-SARS-CoV-2 monoclonal antibodies against postacute sequelae of SARS-CoV-2: analysis of a COVID-19 observational registry for a diverse US metropolitan population. BMJ Open  2023; 13:e067611.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10083521</ArticleId><ArticleId IdType="pubmed">37019490</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzolini  E, Levi  R, Sarti  R, et al.  Association between BNT162b2 vaccination and long COVID after infections not requiring hospitalization in health care workers. JAMA  2022; 328:676–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9250078</ArticleId><ArticleId IdType="pubmed">35796131</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani  D, Bermingham  C, Pouwels  KB, et al.  Trajectory of long COVID symptoms after COVID-19 vaccination: community based cohort study. BMJ  2022; 377:e069676.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauring  AS, Tenforde  MW, Chappell  JD, et al.  Clinical severity of, and effectiveness of mRNA vaccines against, COVID-19 from Omicron, Delta, and Alpha SARS-CoV-2 variants in the United States: prospective observational study. BMJ  2022; 376:e069761.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8905308</ArticleId><ArticleId IdType="pubmed">35264324</ArticleId></ArticleIdList></Reference><Reference><Citation>Bobrovitz  N, Ware  H, Ma  X, et al.  Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the Omicron variant and severe disease: a systematic review and meta-regression. Lancet Infect Dis  2023; 23:556–67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10014083</ArticleId><ArticleId IdType="pubmed">36681084</ArticleId></ArticleIdList></Reference><Reference><Citation>Li  R, Liu  H, Fairley  CK, et al.  Cost-effectiveness analysis of BNT162b2 COVID-19 booster vaccination in the United States. Int J Infect Dis  2022; 119:87–94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8938315</ArticleId><ArticleId IdType="pubmed">35338008</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Fusco  M, Marczell  K, Deger  KA, et al.  Public health impact of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) in the first year of rollout in the United States. J Med Econ  2022; 25:605–17.</Citation><ArticleIdList><ArticleId IdType="pubmed">35574613</ArticleId></ArticleIdList></Reference><Reference><Citation>Ely  EW, Brown  LM, Fineberg  HV. Long COVID Defined. Mass Medical Soc; 2024.</Citation><ArticleIdList><ArticleId IdType="pubmed">39083764</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte  KI, Catahay  JA, Velasco  JV, et al.  Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: a systematic review. EClinicalMedicine  2022; 53:101624.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipsitch  M, Tchetgen Tchetgen  E, Cohen  T. Negative controls: a tool for detecting confounding and bias in observational studies. Epidemiology  2010; 21:383–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3053408</ArticleId><ArticleId IdType="pubmed">20335814</ArticleId></ArticleIdList></Reference><Reference><Citation>Li  KQ, Shi  X, Miao  W, Tchetgen  ET. Double negative control inference in test-negative design studies of vaccine effectiveness. J Am Stat Assoc  2023;119:1859–70. doi:10.1080/01621459.2023.2220935.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01621459.2023.2220935</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>